qER-Quant

by Qure.ai Technologies  · Based in India → — Using artificial intelligence to make healthcare more accessible and affordable.
Neurology Neurosurgery Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Qure.ai’s qER-Quant is an AI-powered software designed for the automated analysis and quantification of non-contrast head CT (NCCT) images. It leverages deep learning algorithms to precisely quantify volumes of intracranial structures and lesions, including intracranial hyperdensities, lateral ventricles, and midline shift. This tool assists clinicians in rapidly assessing the severity of conditions such as traumatic brain injury (TBI), hemorrhagic stroke, and hydrocephalus.

The software is intended to automate the manual process of identifying, labeling, and quantifying brain structures, providing quantitative measurements that aid in diagnostic and treatment decisions. It also supports the comparison of multiple CT scans over time to monitor disease progression. qER-Quant integrates into standard radiology workflows, supporting various input and output formats like DICOM, PDF, and free text. Qure.ai emphasizes data privacy and security, adhering to HIPAA and GDPR standards, and offers flexible deployment options including cloud-based and on-premise solutions.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Quantification of intracranial hyperdensities
  • Quantification of lateral ventricles
  • Quantification of midline shift
  • Automatic labeling and visualization of brain structures
  • Assists in determining severity of trauma, lesion, or underlying disease
  • Comparison of multiple CT scans over time for progression monitoring
  • Reduces door-to-scan interpretation times
  • Accelerates communication of critical results to stroke teams
  • Integration with standard reading environments (PACS/RIS)
  • Supports DICOM GSPS, DICOM secondary capture, PDF, and free text output

Use Cases

  • Assessing injury severity in traumatic brain injury (TBI)
  • Assessing injury severity in hemorrhagic stroke
  • Assessing injury severity in hydrocephalus
  • Monitoring progression of neurological conditions
  • Emergency room triage and prioritization of critical cases
  • Supporting diagnostic and treatment decisions for neurocritical care

What Physicians Need to Know

Stroke Detection Speed
qER-Quant, as part of the broader qER suite, contributes to rapid stroke care by providing quantitative measurements that aid in timely decision-making. The qER system can accelerate communication of critical results to stroke teams within 5 minutes and reduce door-to-scan interpretation times by up to 96%. The processing time for qER-Quant itself is typically 10-60 seconds.
Brain MRI/CT Analysis
qER-Quant is specifically designed for the analysis of non-contrast head CT (NCCT) images. It utilizes deep learning algorithms to quantify the volume of intracranial structures and lesions, including intracranial hyperdensities (ICH and its subtypes), lateral ventricles, and midline shift. The software provides segmentation overlays and tabular reports of volumes, and can be used to track the progression of pathology over time.
Neurodegenerative Disease Screening
While not a broad screening tool for all neurodegenerative diseases, qER-Quant's ability to quantify intracranial structures like lateral ventricles and track the progression of pathologies over time can assist in the management and monitoring of conditions such as hydrocephalus.
Triage Prioritization Speed
qER-Quant's quantification capabilities are integral to the qER system's ability to prioritize critical cases. The qER solution integrates into the radiology workflow, flagging suspected positive findings such as intracranial hemorrhage, mass effect, midline shift, and cranial fractures, and prioritizing them for review. This helps reduce the time to open critical scans and accelerates clinical decision-making.
ASPECTS Score Automation
The qER system, which includes qER-Quant's quantification, provides automated ASPECTS scoring. This helps clinicians assess the severity of acute ischemic stroke, particularly for middle cerebral artery (MCA) stroke patients, and facilitates treatment decisions.
Mobile Notification System
As part of Qure.ai's Stroke Care Suite, qER (and by extension, the insights from qER-Quant) supports a mobile notification system. This enables real-time case notifications and alerts, allowing clinical teams to receive high-priority alerts immediately upon stroke diagnosis and view images on mobile devices as soon as they are acquired.
Physician Tip

Leverage qER-Quant's precise volumetric quantification of intracranial hyperdensities, lateral ventricles, and midline shift to objectively assess injury severity and track pathology progression over time. This quantitative data can enhance diagnostic confidence, support treatment planning, and facilitate consistent monitoring, especially in conditions like hemorrhagic stroke, traumatic brain injury, and hydrocephalus. Utilize the automated ASPECTS scoring for rapid evaluation of ischemic stroke severity. Integrate the mobile notifications for immediate alerts on critical findings to expedite patient triage and team activation.

qER-Quant is designed for seamless integration into existing radiology workflows. It interacts with Picture Archiving and Communication Systems (PACS) to receive scans and return results, and can also integrate with Radiological Information Systems (RIS). Deployment options include cloud-based or locally virtualized (VM, Docker) solutions, and it supports integration via AI marketplaces or distribution platforms.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentCloud-based; Locally virtualized (virtual machine, Docker); On-premise
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

qER-Quant received US FDA 510(k) clearance (K211222) on July 30, 2021, as an automated Radiological Image Processing Software. It is intended for automatic labeling, visualization, and quantification of intracranial hyperdensities, lateral ventricles, and midline shift from Non-Contrast head CT (NCCT) images.

Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

What the Web Says

Qure.ai's qER-Quant is an AI-powered software designed to assist physicians in rapidly assessing and quantifying the severity of neurological conditions like traumatic brain injury, hemorrhagic stroke, and hydrocephalus from head CT scans. It has received FDA 510(k) clearance and is praised for its ability to reduce diagnostic errors, accelerate treatment decisions, and monitor disease progression over time. Physicians and healthcare professionals highlight its value in emergency settings and long-term care due to its precision and automation in interpreting CT scans.

Overall: Positive

Strengths

  • Rapid analysis of head CT scans, enabling quicker diagnosis and treatment decisions.
  • Quantification of injury severity and tracking of pathology progression over time.
  • Reduces the margin for human error in CT scan interpretation.
  • FDA 510(k) clearance, solidifying its standing as a reliable medical solution.
  • Seamless integration into existing hospital infrastructure and radiology workflows.
  • Supports billable CPT codes, potentially creating new revenue streams for healthcare facilities.

Limitations

  • No specific cons were found in the provided search results regarding qER-Quant from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra.
  • Some general Qure.ai products require specific alignment with revenue-cycle teams for successful reimbursement coding.
  • Clinical effectiveness for subtle nodules (of other Qure.ai products) depends on specific imaging quality standards.

Based on reviews from: Qure.ai, AuntMinnie, G2, TestDynamics, Imaging Technology News, PR Newswire, Health AI Register, ResearchGate, WallStreetZen, Wall Street Survivor

Last updated: 2026-07-20

Ratings & Reviews

Rate qER-Quant

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Qure.ai
Qure.ai's qER: Reliable AI for Head CT Scans Worldwide
Qure.ai's qER-Quant augments diagnostic and treatment decisions by determining the severity and progression of conditions like hemorrhagic stroke and hydrocephalus. A study validated the qER algorithm against radiologist findings on over 300,000 head CT scans, showing an AUC of 0.96 and reducing interpretation times by up to 96%.
2024-05
unknown
Revolutionizing Healthcare: Qure.AI's Innovations in Medical Diagnosis and Treatment
This article reviews Qure.ai's innovations in medical diagnosis and treatment, highlighting the efficacy of their AI solutions, including qXR for chest X-ray interpretation. It emphasizes how AI algorithms enhance diagnostic accuracy, efficiency, and speed by analyzing vast datasets and assisting physicians in interpreting medical data.
2024-06
Medica
Medica and Qure.ai white paper reveals: AI matches radiologists in 93.5% of CT scans in acute imaging workflow
A white paper from Medica and Qure.ai demonstrated a 93.5% overall agreement between radiologists and the qER AI algorithm when analyzing 1,315 non-contrast CT head scans, indicating its potential for bleed detection and prioritization in acute imaging.
unknown
Qure.ai
Qure.ai's qER-Quant Receives FDA Clearance
Qure.ai secured 510(k) clearance from the U.S. FDA for its qER-Quant head CT quantification software, solidifying its leadership in AI-driven medical solutions for critical care imaging. The software assists in assessing and quantifying injury severity in neurological conditions like traumatic brain injury, hemorrhagic stroke, and hydrocephalus.
2021-08
Qure.ai
Qure.ai bags second FDA clearance for Brain CT scan AI
Qure.ai announced U.S. FDA 510(k) clearance for its brain CT quantification product, qER-Quant, enabling clinicians to rapidly and precisely assess injury severity and track pathology progression in conditions such as traumatic brain injury, hemorrhagic stroke, and hydrocephalus.
2021-08
AuntMinnie
Qure.ai secures FDA clearance for qER-Quant - AuntMinnie
AI software developer Qure.ai received U.S. Food and Drug Administration (FDA) 510(k) clearance for its qER-Quant head CT quantification software, designed for assessing injury severity in patients with traumatic brain injury, hemorrhagic stroke, and hydrocephalus, and for tracking pathology progression.
2021-08
accessdata.fda.gov
Qure.ai Technologies July 30, 2021 Pooja Rao Head, Research and Development Level 7, Commerz II, International Business par - accessdata.fda.gov
This FDA document details the 510(k) clearance for Qure.ai's qER-Quant software, indicating its use for automatic labeling, visualization, and volumetric quantification of segmentable brain structures from non-contrast head CT images. The software is intended to automate the manual process of identifying and quantifying intracranial hyperdensities, lateral ventricles, and midline shift.
2021-07
Qure.ai
qER-Quant
qER-Quant's deep learning algorithms quantify the volume of intracranial structures and lesions, providing clinicians with measurements to assist in determining trauma severity or comparing multiple CT scans. It is CE Certified (Class IIa) and FDA 510(k) cleared (Class II), with two peer-reviewed papers supporting its efficacy.
2026-05

Videos

Product demos, reviews, and walkthroughs for qER-Quant.

Loading videos...

View all on YouTube

Frequently Asked Questions

qER-Quant is designed for seamless integration into standard radiology workflows and Picture Archiving and Communication Systems (PACS). It processes non-contrast head CT scans, receiving them from your PACS and returning results, such as segmentation overlays and volume tables, back to the same destination in formats like DICOM, PDF, or free text.
qER-Quant analyzes plain head CT scans from adults to quantify intracranial structures and lesions. It provides measurements for conditions like traumatic brain injury, hemorrhagic stroke, and hydrocephalus, including quantification of intracranial hyperdensities, lateral ventricles, and midline shift.
qER-Quant has received U.S. FDA 510(k) clearance and CE certification for marketing in the European Union. While the search results confirm regulatory approvals, specific details on HIPAA compliance are not explicitly stated, but as an FDA-cleared medical device, it would be expected to adhere to relevant data privacy regulations.
Yes, alternatives to AI-powered quantification include traditional manual segmentation by radiologists. Other AI solutions for medical 3D visualization and analysis exist, such as 3D Slicer, Simpleware, and Invivo5, which offer similar functionalities in the broader medical imaging space. qER-Quant differentiates itself by focusing specifically on rapid and precise quantification for critical neurological conditions on head CTs, aiming to reduce interpretation times.
The pricing model for qER-Quant is subscription-based. The overall cost for a healthcare institution is influenced by factors such as the number of installations required.
The provided information does not explicitly detail specific limitations or potential biases of qER-Quant's AI algorithms. However, studies have shown high accuracy, with qER (which includes qER-Quant features in Europe) demonstrating an AUC of 0.96 and excellent concordance with manual segmentation for hematoma volume quantification. The solution has been extensively tested and proven accurate across diverse patient demographics and scanning equipment globally.

Related Tools

Nelli (Version 7.11)
Neuro Event Labs Oy
Neurology AI
Nelli is an AI-driven video and audio monitoring system designed to identify and prioritize the review of seizure events with positive motor components, primarily for epilepsy diagnostics and monitoring.
Rapid Enterprise Platform
RapidAI
Cardiology AI
RapidAI's Enterprise Platform offers FDA-cleared, deep clinical AI solutions that connect imaging to clinical action across the health system, integrating with EHRs and PACS for enhanced decision-making and workflow efficiency.
Neuropacs Parkinsonian Syndromes
Neuropacs
Clinical Decision Support & Reference
Neuropacs™ is an FDA-cleared AI-based software that analyzes patient-specific diffusion MRI data to help radiologists and neurologists differentiate Parkinson's disease from atypical parkinsonian syndromes like multiple system atrophy Parkinsonian variant (MSAp) and progressive supranuclear palsy (PSP).
StateViewer
Mayo Clinic
Clinical Decision Support & Reference
Mayo Clinic's StateViewer is an AI platform under research that analyzes PET scans to identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, aiding in early and precise diagnosis. It has shown to improve diagnostic accuracy and speed of interpretation for clinicians.
NaoTrac
Brain Navi Biotechnology
Neurology AI
NaoTrac is an autonomous neurosurgical navigation robot with AI and machine vision, designed to improve accuracy, streamline procedures, and assist in surgical pathway planning with 3D vision.
GIA® by Scienza Health
Scienza Health
Clinical Decision Support & Reference
GIA® by Scienza Health is a multimodal AI screening platform that combines speech biomarkers with computer vision data to screen for cognitive, neurological, and behavioral conditions like Parkinson's disease and cognitive decline.

See all Neurology AI tools →

More from Qure.ai Technologies

qCT LN Quant
Qure.ai Technologies
Oncology AI
Qure.ai's qCT LN Quant is an FDA-cleared AI solution for advanced quantitative characterization and tracking of solid lung nodules on chest CT scans, supporting early detection and management of lung cancer.
qER
Qure.ai Technologies
Neurology AI
qER by Qure.ai is an FDA-cleared AI-powered solution for the rapid detection and triage of stroke and traumatic brain injury (TBI) on head CT scans, providing real-time alerts and comprehensive findings to accelerate emergency care decisions.
qER-CTA
Qure.ai Technologies
Neurology AI
Qure.ai's qER-CTA is an FDA-cleared AI solution for rapid detection and triage of Large Vessel Occlusions (LVOs) on head CTA scans, designed to accelerate stroke diagnosis and treatment in emergency settings.
qXR-BT
Qure.ai Technologies
Radiology & Imaging AI
Qure.ai's qXR-BT is an FDA-cleared AI algorithm that automates the assessment of breathing tube placement on adult chest X-rays, providing rapid and accurate positional analysis to aid clinicians in critical care settings.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.